Entre 2012 y 2019, Colombia implementó una estrategia clave: la inclusión periódica de tecnologías sanitarias en el PBS, financiado por la Unidad de Pago por Capitación (UPC). Esta medida busca avanzar hacia una mayor cobertura de tecnologías sanitarias sin comprometer la sostenibilidad financiera del sistema de salud. Un estudio realizado por el IETS encuentra resultados reveladores.
This study aimed to estimate the cost-effectiveness relationship of insulins and insulin analogs in diabetes mellitus type 1 (DM1) and 2 (DM2), from the perspective of the Colombian health system. The results favor the use of analog insulins over human insulins, the former reducing the possibility of acute events and chronic complications to a greater extent.
The result of this research shows the economic and clinical benefits of the
use of different pharmacological treatments for adult kidney transplant
recipients in Colombia, considering the years of life gained and organ
rejection avoided. Tacrolimus and cyclosporine are the most used options in
clinical practice for maintenance therapy and are included in the cost-
effective schemes.
Across the different sets of evidence, tacrolimus+mycophenolate
mofetil+corticosteroids, cyclosporine + mycophenolate
mofetil+corticosteroids, and cyclosporine+ azathioprine+corticosteroids
proved to be the cost-effective strategies in most comparisons.
Social preference values of health states are a fundamental input for the preparation of studies in health economics. Several countries have undertaken studies to obtain these values. Our objective was to conduct a structured and systematic literature review of articles that calculates this set of representative values at the national level in low- and middle-income countries (LMICs).
Tacrolimus and cyclosporine are the most used options in clinical practice for maintenance therapy. In this study, we performed a cost-effectiveness analysis of tacrolimus versus cyclosporine, evaluating the cost-effective therapeutic scheme in the Colombian context, considering organ rejection avoided as a clinical outcome. The result of this research shows the economic and clinical benefits of the use of both therapeutic schemes, tacrolimus only achieves cost-effectiveness in 1 treatment regimen, being above the cost-effectiveness threshold in the remaining regimen.
Although recommender systems have been used in a wide variety of products, they have not had the same adoption in the insurance sector due to the particular aspects of the industry. The present research proposes a novel model that uses natural language processing techniques and a deep learning-based model to recommend occupational hygiene services. The results of ranking methods showed that the model combining memorization and generalization of companies’ activities preferences performed better compared to other models. These findings have significant implications for decision-making as they can improve the welfare of both companies and workers, while also limiting the options offered to clients based on their unique profiles.
The result of this research shows the economic and clinical benefits of the use of different pharmacological treatments for adult kidney transplant recipients in Colombia, considering the years of life gained and organ rejection avoided. Tacrolimus and cyclosporine are the most used options in clinical practice for maintenance therapy and are included in the cost-effective schemes.
Across the different sets of evidence, tacrolimus+mycophenolate mofetil+corticosteroids, cyclosporine + mycophenolate mofetil+corticosteroids, and cyclosporine+ azathioprine+corticosteroids proved to be the cost-effective strategies in most comparisons.
Some reports suggest there are differences in health needs between the population affiliated to the subsidized health insurance scheme (SS) and those affiliated to the contributory health insurance scheme (CS) in Colombia. The objective of this study was to identify the epidemiological profile of the population affiliated to the SS in Colombia and to compare the main epidemiological features of the SS to the CS.
El Régimen Subsidiado (RS) del sistema de salud colombiano tiene problemáticas estructurales que no han sido solucionadas y son pocos los estudios que profundizan en la explicación de estas. El objetivo de este trabajo fue explorar la experiencia en la dirección estratégica y gestión operativa y financiera de este régimen, sus aspectos operativos y de gestión del riesgo en esta población, así como las diferencias percibidas frente al Régimen Contributivo.
Some reports suggest there are differences in health needs between the population affiliated to the subsidized health insurance scheme (SS) and those affiliated to the contributory health insurance scheme (CS) in Colombia. The objective of this study was to identify the epidemiological profile of the population affiliated to the SS in Colombia and to compare the main epidemiological features of the SS to the CS.
